Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsive” Patients with Eosinophilic Esophagitis
Journal of Gastrointestinal and Liver Diseases · 2023
DOI: 10.15403/jgld-4746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2023. Verfasst von Kisan P Thakkar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina Scho…. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background and Aims: Some eosinophilic esophagitis (EoE) patients can have a decline in eosinophil count after proton pump inhibitor (PPI) treatment without achieving histologic response, but little is known about this group. We aimed to determine the effect of PPIs on reducing esophageal eosinophilia in patients deemed non-responsive to PPI therapy.
Methods
We analyzed prospectively collected cohort data from newly diagnosed adults with EoE who were histologic non-responders (≥15 eos/hpf) to PPI-only therapy. Symptoms, endoscopic histologic features were assessed before and after PPI. Pre- and post-PPI treatment esophageal biopsies were read by pathologists to determine peak eosinophil counts and other histologic findings.
Results
Of 125 patients, peak eosinophil counts were 102.1 ± 69.8 and 102.9 ± 101.1 (p=0.93) before and after PPI treatment, respectively, but lamina propria fibrosis decreased from 97% to 41% (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. . kisan_thakkar@med.unc.edu.
- Northern Adelaide Local Health Network (NALHN), Department of Gastroenterology Lyell McEwin and Modbury Hospitals, University of Adelaide, South Australia. hamish.philpott@outlook.com.
- Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. sean_lafata@med.unc.edu.
- Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. fowler5152@gmail.com.
- Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Staci.Keene@unchealth.unc.edu.
- Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Alina.Iuga@unchealth.unc.edu.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
Zitieren
APA
Thakkar, K. P., Philpott, H., Lafata, S., Fowler, M., Keene, S., Iuga, A., & Dellon, E. (2023). Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsive” Patients with Eosinophilic Esophagitis. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-4746
Vancouver
Thakkar KP, Philpott H, Lafata S, Fowler M, Keene S, Iuga A, et al. Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsive” Patients with Eosinophilic Esophagitis. Journal of Gastrointestinal and Liver Diseases. 2023. doi:10.15403/jgld-4746
BibTeX
@article{Thakkar2023,
author = {Thakkar, Kisan P and Philpott, Hamish and Lafata, Sean and Fowler, Mark and Keene, Staci and Iuga, Alina and Dellon, E},
title = {Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsive” Patients with Eosinophilic Esophagitis},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2023},
doi = {10.15403/jgld-4746}
}
EUVIMED